INAB
INAB
NASDAQ · Biotechnology

In8Bio Inc

$1.41
-0.06 (-4.08%)
Financial Highlights (FY 2025)
Revenue
7.34M
Net Income
836.8K
Gross Margin
44.0%
Profit Margin
11.4%
Rev Growth
+8.2%
D/E Ratio
0.19
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 44.0% 44.0% 44.0%
Operating Margin 11.2% 10.6% 10.5%
Profit Margin 11.4% 9.2% 10.6%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 7.34M 7.69M 6.20M
Gross Profit 3.24M 3.39M 2.73M
Operating Income 822.5K 817.5K 654.1K
Net Income 836.8K 704.4K 655.3K
Gross Margin 44.0% 44.0% 44.0%
Operating Margin 11.2% 10.6% 10.5%
Profit Margin 11.4% 9.2% 10.6%
Rev Growth +8.2% -3.9% -5.2%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 2.59M 2.45M 2.40M
Total Equity 13.81M 12.60M 13.17M
D/E Ratio 0.19 0.19 0.18
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 1.33M 1.40M 1.15M
Free Cash Flow 524.0K 541.1K 340.9K